Reports Q3 revenue $5.1B, consensus $5.08B. GE HealthCare (GEHC) President and CEO Peter Arduini said, “We delivered robust orders with growth across all segments in the third quarter. This was led by customer demand for our differentiated solutions and a healthy capital equipment environment. Revenue performance was driven by Imaging, Advanced Visualization Solutions, and Pharmaceutical Diagnostics, and was ahead of our expectations. We continue to see momentum with commercial execution, where our teams leverage our broad portfolio and services, creating sustainable revenue and strengthening customer relationships. As a result of our increased R&D investments, we are entering a new wave of innovation and, coupled with our focus on lean, we expect to accelerate top and bottom line growth.”
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GEHC:
- Notable companies reporting before tomorrow’s open
- GE HealthCare receives CE mark for Carevance patient monitor
- GE HealthCare announces collaborations with two medical systems on AI technology
- Intel downgraded, Micron upgraded: Wall Street’s top analyst calls
- GE HealthCare price target raised to $89 from $87 at BTIG
